Nigerian HIV type 2 subtype A and B from heterotypic HIV type 1 and HIV type 2 or monotypic HIV type 2 infections

AIDS Research and Human Retroviruses

Volumn 21, Issue 1, 2005, Pages 17-27

  Zeh, Clement ^a   Pieniazek, Danuta ^a   Agwale, Simon M ^a,b   Robbins, Kenneth E ^a   Odama, Lillian ^b   Sani Gwarzo, N ^c   Gboun, Michael S ^c   Inyang, Uford S ^c   Folks, Thomas M ^a   Wambebe, Charles ^c   Kalish, Marcia L ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b NATIONAL INSTITUTE FOR PHARMACEUTICAL RESEARCH AND DEVELOPMENT   (Nigeria)

^c Federal Ministry of Health   (Nigeria)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS ANTIBODY;

ANTIBODY DETECTION; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; ELECTROIMMUNOASSAY; GENE SEQUENCE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 2; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MORBIDITY; NIGERIA; NONHUMAN; PHYLOGENY; PRIORITY JOURNAL; VIRUS STRAIN; VIRUS TYPING;

DNA, VIRAL; GENOTYPE; HIV ANTIBODIES; HIV ENVELOPE PROTEIN GP41; HIV INFECTIONS; HIV PROTEASE; HIV-1; HIV-2; HUMANS; MOLECULAR SEQUENCE DATA; NIGERIA; PHYLOGENY; POLYMERASE CHAIN REACTION; PREVALENCE; SEQUENCE ANALYSIS, DNA;

EID: 19944433148     PISSN: 08892229     EISSN: None     Source Type: Journal    
DOI: 10.1089/aid.2005.21.17     Document Type: Article

References (60)

1. Kanki PJ, Peeters M, and Gueye-Ndiaye A: Virology of HIV-1 and HIV-2: Implications for Africa. AIDS 1997;11:S33-S42.
2. Ancelle R, Bletry O, Baglin AC, Brun-Vezinet F, Rey MA, and Godeau P: Long incubation period for HIV-2 infection. Lancet 1987;1:688-689.
3. De Cock KM, Adjorlolo G, Ekpini E, Sibailly T, Kouadio J, Maran M, Brattegaard K, Vetter KM, Doorly R, and Gayle HD: Epidemiology and transmission of HIV-2. Why there is no HIV-2 pandemic. JAMA 1993;270:2083-2086.
4. Marlink R, Kanki P, Thior I, Travers K, Eisen G, Siby T, Traore I, Hsieh CC, Dia MC, Gueye EH, Hellinger J, Gueye-Ndiaye A, Sankale JL, Ndoye I, Mboup S, and Essex M: Reduced rate of disease development after HIV-2 infection as compared to HIV-1. Science 1994;265:1587-1590.
5. Popper SJ, Sarr AD, Gueye-Ndiaye A, Mboup S, Essex ME, and Kanki PJ: Low plasma human immunodeficiency virus type 2 viral load is independent of proviral load: Low virus production in vivo. J Virol 2000;74:1554-1557.
6. Adjorlolo-Johnson G, De Cock KM, Ekpini E, Vetter M, Sibailly T, Brattegaard K, Yavo D, Doorly R, Whitaker JP, Kestens L, Ou CY, George RJ, and Gayle HD: Prospective comparison of mother-to-child transmission of HIV-1 and HIV-2 in Abidjan, Ivory Coast. JAMA 1994;272:462-466.
7. Sharp PM, Bailes E, Chaudhuri RR, Rodenburg CM, Santiago MO, and Hahn BH: The origins of acquired immune deficiency syndrome viruses: Where and when? Phil Trans R Soc Lond B 2001;356:867-876.
8. Gao F, Bailes E, Robertson DL, Chen Y, Rodenburg CM, Michael SF, Cummins LB, Arthur LO, Peeters M, Shaw GM, Sharp PM, and Hahn BH: Origin of HIV-1 in the chimpanzee Pan troglodytes troglodytes. Nature 1999;397:436-441.
9. Sharp PM, Bailes E, Robertson DL, Gao F, and Hahn BH: Origins and evolution of AIDS viruses. Biol Bull 1999;196:338-342.
10. Hahn B H, Shaw GM, De Cock KM, and Sharp PM: AIDS as a zoonosis: Scientific and public health implications. Science 2000;287:607-614.
11. Chen Z, Luckay A, Sodora DL, Telfer P, Reed P, Gettie A, Kanu JM, Sadek RF, Yee J, Ho DD, Zhang L, and Marx PA: Human immunodeficiency virus type 2 (HIV-2) seroprevalence and characterization of a distinct HIV-2 genetic subtype from the natural range of simian immunodeficiency virus-infected sooty mangabeys. J Virol 1997;71:3953-3960.
12. Gao F, Yue L, Robertson DL, Hill SC, Hui H, Biggar RJ, Neequaye AE, Whelan T M, Ho DD, and Shaw GM: Genetic diversity of human immunodeficiency virus type 2: Evidence for distinct sequence subtypes with differences in virus biology. J Virol 1994;68:7433-7447.
13. Yamaguchi J, Devare SG, and Brennan CA: Identification of a new HIV-2 subtype based on phylogenetic analysis of full-length genomic sequence. AIDS Res Hum Retroviruses 2000;16:925-930.
14. Bouckenooghe A and Shandera W: HIV trends in African blood donors. J Infect 1999;39:122-128.
15. Marlink R: Lessons from the second AIDS virus, HIV-2. AIDS 1996;10:689-699.
16. Peeters M, Koumare B, Mulanga C, Brengues C, Mounirou B, Bougoudogo F, Ravel S, Bibollet-Ruche F, and Delaporte E: Genetic subtypes of HIV type 1 and HIV type 2 strains in commercial sex workers from Bamako, Mali. AIDS Res Hum Retroviruses 1998;14:51-58.
17. Sarr AD, Sankale JL, Gueye-Ndiaye A, Essex M, Mboup S, Kanki PJ: Genetic analysis of HIV type 2 in monotypic and dual HIV infections. AIDS Res Hum Retroviruses 2000;16:295-298.
18. Takehisa J, Osei-Kwasi M, Ayisi NK, Hishida O, Miura T, Igarashi T, Brandful J, Ampofo W, Netty VB, Mensah M, Yamashita M, Ido E, and Hayami M: Phylogenetic analysis of HIV type 2 in Ghana and intrasubtype recombination in HIV type 2. AIDS Res Hum Retroviruses 1997;13:621-623.
19. Takehisa J, Zekeng L, Ido E, Mboudjeka I, Moriyama H, Miura T, Yamashita M, Gurtler LG, Hayami M, and Kaptue L: Various types of HIV mixed infections in Cameroon. Virology 1998;245:1-10.
20. Xiang Z, Ariyoshi K, Wilkins A, Dias F, Whittle H, and Breuer J: HIV type 2 pathogenicity is not related to subtype in rural Guinea Bissau. AIDS Res Hum Retroviruses 1997;13:501-505.
21. Pieniazek D, Ellenberger D, Janini LM, Ramos AC, Nkengasong J, Sassan-Morokro M, Hu DJ, Coulibally IM, Ekpini E, Bandea C, Tanur A, Greenberg AE, Wiktor SZ, and Rayfield MA: Predominance of human immunodeficiency virus type 2 subtype B in Abidjan, Ivory Coast. AIDS Res Hum Retroviruses 1999;15:603-608.
22. Dada AJ, Oyewole F, Onofowokan R, Nasidi A, Harris B, Levin A, Diamondstone L, Quinn TC, and Blattner WA: Demographic characteristics of retroviral infections (HIV-1, HIV-2, and HTLV-I) among female professional sex workers in Lagos, Nigeria. J Acquir Immune Defic Syndr 1993;6:1358-1363.
23. Esu-Williams E, Mulanga-Kabeya C, Takena H, Zwandor A, Aminu K, Adamu I, Yetunde O, Akinsete I, Patrel D, Peeters M, and Delaporte E: Seroprevalence of HIV-1, HIV-2, and HIV-1 group O in Nigeria: Evidence for a growing increase of HIV infection. J Acquir Immune Defic Syndr Hum Retrovirol 1997;16:204-210.
24. Kline L, Dada A, Blattner W, and Quinn TC: Diagnosis and differentiation of HIV-1 and HIV-2 infection by two rapid assays in Nigeria. J Acquir Immune Defic Syndr 1994;7:623-626.
25. Agwale SM, Zeh C, Robbins KE, Odama L, Saekhou A, Edubio A, Njoku OM, Sani-Gwarzo N, Gboun MF, Gao F, Reitz M, Hone D, Folks TM, Pieniazek D, Wambebe C, and Kalish ML: Molecular surveillance of HIV-1 field strains in Nigeria in preparation for vaccine trials. Vaccine 2002;3086:1-9.
26. McCutchan FE, Carr JK, Bajani M, Sanders-Buell E, Harry TO, Stoeckli T C, Robbins KE, Gashau W, Nasidi A, Janssens W, and Kalish ML: Subtype G and multiple forms of A/G intersubtype recombinant human immunodeficiency virus type 1 in Nigeria. Virology 1999;254:226-234.
27. Peeters M, Esu-Williams E, Vergne L, Montavon C, Mulanga-Kabeya C, Harry T, Ibironke A, Lesage D, Patrel D, and Delaporte E: Predominance of subtype A and G HIV type 1 in Nigeria, with geographical differences in their distribution. AIDS Res Hum Retroviruses 2000;16:315-325.
28. Agwale SM, Robbins KE, Odama L, Saekhou A, Zeh C, Edubio A, Njoku OM, Sani-Gwarzo N, Gboun MF, Gao F, Reitz M, Hone D, Folks TM, Pieniazek D, Wambebe C, and Kalish LM: Development of an env gp41-based heteroduplex mobility assay for rapid HIV-1 subtyping. J Clin Microb 2001;39:2110-2114.
29. Janini LM, Pieniazek D, Peralta JM, Schechter M, Tanuri A, Vicente AC, dela Torre N, Pieniazek NJ, Luo CC, Kalish ML, Schochetman G, and Rayfield MA: Identification of single and dual infections with distinct subtypes of human immunodeficiency virus type 1 by using restriction fragment length polymorphism analysis. Virus Genes 1996;13:69-81.
30. Pieniazek D, Peralta JM, Ferreira JA, Krebs JW, Owen SM, Simon FS, Filho CF, Sereno AB, de Sa CA, Weniger BG, Heyward WL, Ou CY, Pieniazek NJ, Schochetman G, and Rayfield MA: Identification of mixed HIV-1/HIV-2 infections in Brazil by polymerase chain reaction. AIDS 1991;5:1293-1299.
31. Pieniazek , Baggs J, Hu DJ, Matar GM, Abdelnoor AM, Mokhbat JE, Uwaydah M, Bizri AR, Ramos A, Janini LM, Tanuri A, Fridlund C, Schable C, Heyndrickx L, Rayfield MA, and Heneine W: Introduction of HIV-2 and multiple HIV-1 subtypes to Lebanon. Emerg Infect Dis 1998;4:649-656.
32. Yang C, Dash BC, Simon F, van der Groen G, Pieniazek D, Gao F, Hahn BH, and Lal RB: Detection of diverse variants of human immunodeficiency virus-1 groups M, N, and O and simian immunodeficiency viruses from chimpanzees by using generic pol and env primer pairs. J Infect Dis 2000;181:1791-1795.
33. Yang C, Pieniazek D, Owen SM, Fridlund C, Nkengasong J, Mastro TD, Rayfield MA, Downing R, Biryawaho B, Tanuri A, Zekeng L, van der Groen G, Gao F, and Lal RB: Detection of phylogenetically diverse human immunodeficiency virus type 1 groups M and O from plasma by using highly sensitive and specific generic primers. J Clin Microbiol 1999;37:2581-2586.
34. Higgins DG and Sharp PM: Fast and sensitive multiple sequence alignments on a microcomputer. Comput Appl Biosci 1989;5:151-153.
35. Felsenstein J: PHYLIP-Phylogeny interference package (vesion 3.2). Cladistics 1989;5:164-166.
36. Smith SW, Overbeek R, Woese C., Gilbert W, and Gillevet PM: The genetic data environment an expandable GUI for multiple sequence analysis. Comput Appl Biosci 1994;10:671-675.
37. Wiktor SZ, Nkengasong JN, Ekpini ER, Adjorlolo-Johnson GT, Ghys PD, Brattegaard K, Tossou O, Dondero TJ, De Cock KM, and Greenberg AE: Lack of protection against HIV-1 infection among women with HIV-2 infection. AIDS 1999;13:695-699.
38. Esteves A, Parreira R, Piedade J, Venenno T, and Canas-Ferreira WF: Genetic characterization of HIV type 1 and type 2 from Bissau, Guinea-Bissau (West Africa). Virus Res 2000;68:51-61.
39. Ishikawa K, Fransen K, Ariyoshi K, Nkengasong JN, Janssens W, Heyndrickx L, Whittle H, Diallo MO, Ghys PD, Coulibaly IM, Greenberg AE, Piedade J, Canas-Ferreira W, and van der Groen G: Improved detection of HIV-2 proviral DNA in dually seroreactive individuals by PCR. AIDS 1998;12:1419-1425.
40. George JR, Ou CY, Parekh B, Brattegaard K, Brown V, Boateng E, and De Cock KM: Prevalence of HIV-1 and HIV-2 mixed infections in Cote d'Ivoire. Lancet 1992;340:337-339.
41. Leonard G, Chaput A, Courgnaud V, Sangare A, Denis F, and Brechot C: Characterization of dual HIV-1 and HIV-2 serological profiles by polymerase chain reaction. AIDS 1993;7:1185-1189.
42. Peeters M, Fransen K, Gershy-Damet G, Willems B, Koffi K, Coulibaly M, Piot P, and Van der Groen G: Effect of methodology on detection of HIV-1/HIV-2 dual infections in Cote d'Ivoire. J Virol Methods 1994;48:23-30.
43. Sarr AD, Hamel DJ, Thior I, Kokkotou E, Sankale JL, Marlink R, Coll-Seek EM, Essex ME, Siby T, Mboup S, and Kanki PJ: HIV-1 and HIV-2 dual infection: Lack of HIV-2 provirus correlates with low CD4+ lymphocyte counts. AIDS 1998;12:131-137.
44. Travers K, Mboup S, Marlink R, Gueye-Nidaye A, Siby T, Thior I, Traore I, Dieng-Sarr A, Sankale JL, Mullins C, Ndoye I. Hsieh CC, Essex M, and Kanki P: Natural protection against HIV-1 infection provided by HIV-2. Science 1995;268:1612-1615.
45. Travers KU, Eisen GE, Marlink RG, Essex ME, Hsieh CC, Mboup S, and Kanki PJ: Protection from HIV-1 infection by HIV-2. AIDS 1998;12:224-225.
46. Aaby P, Poulsen AG, Larsen O, Christiansen, CB, Jensen H, Melbye M, Naucler A, and Dias F: Does HIV-2 protect against HIV-1 infection? AIDS 1997;11:939-940.
47. Ariyoshi K, Schim van der Loeff M, Sabally S, Cham F, Corrah T, and Whittle H: Does HIV-2 infection provide cross-protection against HIV-1 infection? AIDS 1997;11:1053-1054.
48. Greenberg AE: Possible protective effect of HIV-2 against incident HIV-1 infection: Review of available epidemiological and in vitro data. AIDS 2001;15:2319-2321.
49. Norrgren H, Andersson S, Biague AJ, da Silva ZJ, Dias F, Naucler A, and Biberfeld G: Trends and interaction of HIV-1 and HIV-2 in Guinea-Bissau, West Africa: No protection of HIV-2 against HIV-1 infection. AIDS 1999;13:701-707.
50. van der Loeff MF, Aaby P, Aryioshi K, Vincent T, Awasana AA, Da Costa C, Pembrey L, Dias F, Harding E, Weiss HA, and Whittle HC: HIV-2 does not protect against HIV-1 infection in a rural community in Guinea-Bissau. AIDS 2001;15:2303-2310.
51. Holmes EC: On the origin and evolution of the human immunodeficiency virus (HIV). Biol Rev Camb Philos Soc 2001; 76:239-254.
52. Altfeld M, Allen TM, Yu XG, Johnston MN, Agrawal D, Korber BT, Montefiori DC, O'Connor DH, Davis BT, Lee PK, Maier EL, Harlow J, Goulder PJ, Brander C, Rosenberg ES, and Walker BD: HIV-1 superinfection despite broad CD8+ T-cell responses containing replication of the primary virus. Nature 2002;420:434-439.
53. Ramos A, Hu DJ, Nguyen L, Phan KO, Vanichseni S, Promadej N, Choopanya K, Callahan M, Young NL, McNicholl J, Mastro TD, Folks TM, and Subbarao S: Intersubtype human immunodeficiency virus type 1 superinfection following seroconversion to primary infection in two injection drug users. J Virol 2002;76:7444-7452.
54. Grez M, Dietrich U, Balfe P, von Briesen H, Maniar JK, Mahambre G, Delwart EL, Mullins JI, and Rubsamen-Waigmann H: Genetic analysis of human immunodeficiency virus type 1 and 2 (HIV-1 and HIV-2) mixed infections in India reveals a recent spread of HIV-1 and HIV-2 from a single ancestor for each of these viruses. J Virol 1994;68:2161-2168.
55. Janini LM, Tanuri A, Schechter M, Peralta JM, Vicente AC, dela Torre N, Pieniazek NJ, Luo CC. Ramos A, Soriano V, Schochetman G, Rayfield MA, and Pieniazek D: Horizontal and vertical transmission of human immunodeficiency virus type 1 dual infections caused by viruses of subtypes B and C. J Infect Dis 1998;177:227-231.
56. Metzker ML, Mindell DP, Liu XM, Ptak RG, Gibbs RA, and Hillis DM: Molecular evidence of HIV-1 transmission in a criminal case. Proc Natl Acad Sci USA 2002;99:14292-14297.
57. Andersson S, Norrgren H, Dias F, Biberfeld G, and Albert J: Molecular characterization of human immunodeficiency virus (HIV)-1 and -2 in individuals from Guinea-Bissau with single or dual infections: Predominance of a distinct HIV-1 subtype A/G recombinant in West Africa. Virology 1999;262:312-320.
58. Naucler A, Albino P, Da Silva AP, Andreasson PA, Andersson S, and Biberfeld G: HIV-2 infection in hospitalized patients in Bissau, Guinea-Bissau. AIDS 1991;5:301-304.
59. Piedade J, Venenno T, Prieto E, Albuquerque R, Esteves A, Parreira R, and Canas-Ferreira WF: Longstanding presence of HIV-2 infection in Guinea-Bissau (West Africa). Acta Trop 2000;76:119-124.
60. Wlodawer A and Erickson JW: Structure-based inhibitors of HIV-1 protease. Annu Rev Biochem 1993;62:543-585.